Navigation Links
Insmed to Present at Sixth Annual JMP Securities Healthcare Conference
Date:9/26/2011

MONMOUTH JUNCTION, N.J., Sept. 26, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, announced today that Timothy Whitten, President and CEO of Insmed, will be presenting a corporate overview at the Sixth Annual JMP Securities Healthcare Conference on Wednesday, September 28, 2011, at 11:30 AM ET, in New York.

A live audio webcast will be available on Insmed's website, http://www.insmed.com.  The webcast will also be archived for 90 days.

About Insmed

Insmed Incorporated is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases, and has a proprietary protein platform aimed at niche markets with high unmet medical need. Insmed's primary focus is on the development of inhaled antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases.  For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to our financial position, results of operations, the status and the results of preclinical studies and clinical trials and preclinical and clinical data described herein, the timing of responses to information and data requests from FDA, the development of our products, and the business strategies, plans and objectives of management, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements.  Our results may be affected by such factors as the receipt and
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
2. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
3. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
4. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
5. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
6. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
7. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
8. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
9. Insmed to Host Third Quarter 2010 Conference Call
10. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2010
11. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 Solta Medical, Inc. (NASDAQ: SLTM ... reported Dr. Edward W. Knowlton has ... effective immediately.  Dr. Knowlton is the founder of Thermage, the ... director since 1996. "On behalf of the entire ... would like to thank Ed for his tireless dedication to ...
(Date:5/24/2013)... 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ... the Deutsche Bank Health Care Conference to be held ... Adrian Adams , Chief Executive Officer ... the Company and its product pipeline at 12:00 p.m. ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will ...
(Date:5/24/2013)... GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, is ... Usui as a Consultant to augment the Company,s business ... territories. Mr Usui has more than 15 years of ... industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ( ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... SyncMedical LLC today announced that the Brazilian ANVISA ... Surveillance Agency) has approved their Ethos Spine ... Spine product line was developed to fulfill the need ... in the ever-growing, ever-changing field of spine surgery. The ...
... 5, 2011 CentraState Healthcare System announced today ... provide state-of-the-art health information exchange (HIE) services to ... laboratories, and other clinicians within its broad medical ... MobileMD to deploy its 4D HIE™, which is ...
Cached Medicine Technology:SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil 2CentraState Healthcare System Selects MobileMD for Health Information Exchange; Introduces EMR Light to Healthcare Community 2CentraState Healthcare System Selects MobileMD for Health Information Exchange; Introduces EMR Light to Healthcare Community 3
(Date:5/24/2013)... GA (PRWEB) May 24, 2013 Started in ... held in Orlando. 2013 marks AMTC’s 31st anniversary. SHINE ... family, starting with supermodel Millie Lewis and her daughter, Carey ... top agents, managers, casting directors, and music professionals including the ... Arts and XP Media. They are kings of Hollywood and ...
(Date:5/24/2013)... highly respected Alzheimer,s researchers failed to replicate what appeared ... brain disease when they were published last year in ... online Feb. 9, 2012, suggested that the drug bexarotene ... beta amyloid plaques (Aβ) a pathological hallmark of ... to the authors of the 2012 report, drug treatment ...
(Date:5/24/2013)... 24, 2013 Amirsys today announces the ... enhancements for instructors and students. Instructors can use the ... personalize learning plan templates, targeted reading assignments, and customized ... new assessment questions, 5,000 searchable anatomy glossary terms, and ... AnatomyOne 2.0 is the first gross anatomy resource ...
(Date:5/24/2013)... 2013 Mr. Brian Su, CEO of ... EB-5 Investment Summit: Dealmakers Conference in Long Beach, California ... on exploring alternative finance through EB-5 immigrant investors program. ... economic information, and updates to project developers, regional center ... , "Our goal is to assist EB-5 projects ...
(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... of Yahoo Commerce VP, Brandon Huff as Executive Vice ... ran its commerce business units, which represented a large ... will lead digital growth as Dwell develops a fully-integrated ... him a decade of experience monetizing digital content for ...
Breaking Medicine News(10 mins):Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2
... PHILADELPHIA, August 5, 2008 The U.S. Preventive Services ... against routine prostate cancer screening for men over the ... if men under 75 could benefit from screening. ... insufficient scientific evidence to recommend screening for all men, ...
... injections of vitamin C, also known as ascorbate or ... about 50 percent in mouse models of brain, ovarian, ... Health (NIH) report in the August 5, 2008, issue ... Sciences . The researchers traced ascorbate,s anti-cancer effect ...
... but watch less TV , , MONDAY, Aug. 4 (HealthDay ... active and less likely to participate in sports than U.S.-born ... from the 2003 National Survey of Children,s Health and found ... while 73.5 percent were physically active three or more days ...
... force reports , , MONDAY, Aug. 4 (HealthDay News) -- ... cancer screenings at any age and flatly recommend against ... rule "is much more explicit than any recommendation out ... test, said Dr. Michael L. LeFevre, a member of ...
... nutraceutical moves,to the forefront of those supplements ... Eniva,s Efacor has recently received industry recognition ... has long been recognized as the "gold-testing ... CL,s stringent testing of the Eniva,Efacor product ...
... Florida Market, NORTH HOLLYWOOD, Calif., Aug. 4 ... ), a leading national hospitalist,physician group practice, announced ... Hospitalists of America (HOA). The acquisition,expands IPC,s presence ... a network of independent physicians, who perform hospitalist,services ...
Cached Medicine News:Health News:Vitamin C injections slow tumor growth in mice 2Health News:Vitamin C injections slow tumor growth in mice 3Health News:Immigrant Children Less Likely to Exercise 2Health News:New Guidelines Rule Out Prostate Screening for Men Over 75 2Health News:New Guidelines Rule Out Prostate Screening for Men Over 75 3Health News:New Guidelines Rule Out Prostate Screening for Men Over 75 4Health News:Eniva USA Efacor(R) Fish Oil (Non-Fishy Lemon Taste) Receives ConsumerLab.com Seal of Approval 2Health News:IPC The Hospitalist Company Completes Acquisition of Hospitalists of America 2
... The Quinton Q-Stress Cardiac Stress ... baseline wander and muscle artifact ... second to provide the highest ... Leads can be displayed in ...
... cardiac diagnosis, the fully featured CH2000 Stress ... stress test system that measures T-wave alternans ... check provides a quality control facility, this ... dynamically filters the signal ensuring outstanding and ...
... Marco's CP-690E Automatic Chart Projector makes refracting easier ... program up to 33 charts in any order ... in a darkened room simply by pressing one ... the next chart. In addition, the CP-690E's programmable ...
The Urchin heart positioner provides excellent access to target coronaries while minimizing hemodynamic instability...
Medicine Products: